Skip to main content
. 2022 Oct 30;28(4):642–654. doi: 10.5056/jnm21202

Figure 3.

Figure 3

Differentially abundant taxa in the probiotic and placebo groups. The taxa that were identified as differentially abundant by DESeq2 (A) at the baseline and (B) after probiotics treatment are listed. Several taxa, including Faecalimonas umbilicata, Bifidobacterium bifidum, Pediococcus acidilactici, and Enterococcus faecium, which did not differ in abundance between the 2 groups in pre-treatment samples (A) were abundant in the post-treatment fecal samples of the probiotic group (B).